Alpine Associates Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Alpine Associates Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,364,900	Closed	-$32.9M	–	53
2023 Q1	$32.9M	Buy	+1,364,900	New	+$17.1M	1.76%	20

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Alpine Associates Management's PRVB Position: Q2 2023 in Review

Alpine Associates Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 1,364,900 shares — an estimated $32.9M sold.

Alpine Associates Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $32.9M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Alpine Associates Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Alpine Associates Management sold 1,364,900 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $32.9M.
Alpine Associates Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Alpine Associates Management's Provention Bio, Inc. Common Stock position peaked at $32.9M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Alpine Associates Management's 13F filing for Q2 2023, filed 10 Aug 2023.